By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Genome British Columbia has started a new Personalized Medicine Program, which includes financial support from the non-profit BC Cancer Foundation, by awarding an initial investment of around C$9 million ($9.4 million) in funding to three studies.

The new program seeks to use genomics research to tailor improved treatments for patients, to mitigate ineffective treatments and side effects, and to use genomic knowledge in disease prevention and early diagnosis.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

A research duo estimates in PLOS One the number of papers that have used misidentified cell lines.

UK's National Institute for Health and Care Excellence approves GlaxoSmithKline's SCID gene therapy despite cost.

Science reports that Brazilian researchers are petitioning for the reversal of budget cuts.

In PLOS this week: gene flow patterns in common ash, guidelines for using morpholinos in zebrafish, and more.